Global Cannabis Industry Continues Gaining Ground in Central and South America
SAN DIEGO, CA – June 30, 2016 — Medical Marijuana, Inc. (OTC: MJNA) announced today that the Paraguay government has issued a new import permit for the Company’s flagship product Real Scientific Hemp Oil™ (RSHO™) for a new patient in the country. The Company also announced its plans to further expand into Latin America as the cannabis industry continues gaining ground in the region and as demand for its products increase.
The Paraguay government granted the country’s first-ever import permit for RSHO™ in May 2016, which marked the third country in Latin America, after Brazil and Mexico to approve Medical Marijuana, Inc.’s cannabidiol (CBD) hemp oil for indications including epilepsy, Parkinson’s disease and chronic pain. RSHO™ also has 12 medical product registrations in Puerto Rico.
“We are thrilled to hear the news that the Paraguay government has issued another import permit for a suffering child, so soon after its government granted the first-ever import just a month ago,” states Dr. Stuart Titus, Chief Executive Officer of Medical Marijuana, Inc. “As evident with other countries we ship our products to, demand increases once the word spreads. We expect demand to continue to increase in Paraguay, and in the other countries that are receiving shipments of RSHO™.”
Medical Marijuana, Inc. also announced its plans to further expand into the Latin America marketplace, and that the Company is working on opening a fourth new Latin American market. Currently, Medical Marijuana, Inc.’s RSHO™ products are shipping to more than 40 countries.
“We’re excited about the opportunity to get our products to more patients in Latin America and throughout the world,” added Dr. Titus. “The medical marijuana industry is experiencing significant growth in South and Central American countries as a shift in public attitudes, legislative development, and a greater awareness of cannabis’ medicinal properties continues. As more and more countries come on board, our Company is ready to provide them with the products they need to help patients who have been suffering too long.”
About Medical Marijuana, Inc.
Our mission is to be the premier cannabis and hemp industry innovators, leveraging our team of professionals to source, evaluate and purchase value-added companies and products, while allowing them to keep their integrity and entrepreneurial spirit. We strive to create awareness within our industry, develop environmentally-friendly, economically sustainable businesses, while increasing shareholder value. For details on Medical Marijuana, Inc.’s portfolio and investment companies, visit www.medicalmarijuanainc.com.
This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of Medical Marijuana, Inc. to be materially different from the statements made herein.
FOOD AND DRUG ADMINISTRATION (FDA) DISCLOSURE
These statements have not been evaluated by the FDA and are not intended to diagnose, treat or cure any disease.
Medical Marijuana Inc. does not sell or distribute any products that are in violation of the United States Controlled Substances Act (US.CSA). These companies do grow, sell, and distribute hemp-based products and are involved with the federally legal distribution of medical marijuana-based products within certain international markets. Cannabidiol is a natural constituent of hemp oil.
Public Relations Contact:
Chief Executive Officer
Corporate Business Contact:
Nicholas R. Massalas
Director of Business Development
Medical Marijuana, Inc.
OTC Symbol: MJNA
Toll Free: 888-OTC- MJNA (888-682- 6562)
Investor Relations Contact:
Toll Free: (877) 964.6463
Office/Direct: (858) 264-6500
Email: [email protected][/vc_column_text][/vc_column][/vc_row]